United States· US:54181-015_5b1cf88b-582f-b5a0-e063-6294a90abd47
Pur Confort SPF 15
A medicinal product containing avobenzone; homosalate; octinoxate; octisalate; octocrylene, registered in United States by Guinot.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE
- Manufacturer
- Guinot
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1154181-015-50
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/150d311d-1c4a-4a9e-a0b4-b4e4ba3b60f2 GET /v1/drugs/150d311d-1c4a-4a9e-a0b4-b4e4ba3b60f2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "28.5; 50; 70; 30; 90",
"substance": "AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE",
"productndc": "54181-015",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "mg/mL; mg/mL; mg/mL; mg/mL; mg/mL",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about avobenzone; homosalate; octinoxate; octisalate; octocrylene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.